Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Improved brain scan specificity utilizing 99mTc-pertechnetate and 99mTc(Sn)-diphosphonate.

K C Fischer, K A McKusick, H P Pendergrass

    Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
    |August 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Can infections be imaged in implanted devices?

    ASAIO journal (American Society for Artificial Internal Organs : 1992)·2000
    Same author

    Prognostic value of dipyridamole thallium imaging after acute myocardial infarction in older patients.

    Journal of the American Geriatrics Society·1999
    Same author

    Unilateral hypoperfusion or absent perfusion on pulmonary scintigraphy: differential diagnosis.

    AJR. American journal of roentgenology·1998
    Same author

    Perfusion scintigraphy in the evaluation for lung volume reduction surgery: correlation with clinical outcome.

    Radiology·1997
    Same author

    Procedure guideline for lung scintigraphy: 1.0. Society of Nuclear Medicine.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·1996
    Same author

    Employment status of physicians completing training.

    JAMA·1996
    Same journal

    Overall Survival with [<sup>177</sup>Lu]Lu-PSMA-617 Versus [<sup>177</sup>Lu]Lu-PSMA I&T: A Propensity Score-Matched Real-World Analysis.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
    Same journal

    Toward a Biopsy-Free Diagnosis of Prostate Cancer: Potential of Combined <sup>18</sup>F-Flotufolastat PSMA PET and mpMRI.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
    Same journal

    PSMA PET/CT-Targeted Biopsy in Men with Negative or Equivocal Multiparametric MRI and Exploratory Dynamic Total-Body PET: The FUPERMAN Study.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
    Same journal

    Erratum.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
    Same journal

    Live from 2026 SNMMI Annual Meeting in Los Angeles!

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
    Same journal

    CAR T-Cell Therapy for Cancer: Updates and Challenges for Response Assessment.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
    See all related articles

    This study compared two radiopharmaceuticals for brain imaging. Technetium-99m-pertechnetate excelled at detecting tumors, while technetium-99m-tin-diphosphonate was better for cerebral infarctions.

    Area of Science:

    • Nuclear Medicine
    • Radiopharmacology
    • Neurology

    Background:

    • Accurate brain lesion detection is crucial for diagnosis and treatment.
    • Differentiating between cerebral infarctions and tumors (gliomas, metastases) can be challenging.
    • Evaluating the efficacy of different radiopharmaceuticals in specific neuropathologies is essential.

    Purpose of the Study:

    • To compare the diagnostic utility of technetium-99m-pertechnetate and technetium-99m-tin-diphosphonate in brain imaging.
    • To determine which radiopharmaceutical is superior for visualizing cerebral infarctions versus brain tumors.
    • To assess the value of a dual-tracer approach in neuroimaging.

    Main Methods:

    • Sequential brain scintigraphy was performed on 36 patients using 20 mCi of 99mTc-pertechnetate and 20 mCi of 99mTc(Sn)-diphosphonate.

    Related Experiment Videos

  • Scans were qualitatively compared, and lesion-to-nonlesion activity ratios were determined.
  • Clinical diagnoses were supported by CT scans, angiography, and in some cases, histology.

    • Main Results:

    • Technetium-99m-tin-diphosphonate demonstrated 15 of 22 cerebral infarctions better than 99mTc-pertechnetate.
    • Technetium-99m-pertechnetate visualized 11 of 12 tumors better than 99mTc(Sn)-diphosphonate.
    • No lesions were exclusively visualized by one agent over the other; dual imaging aids differentiation.

    Conclusions:

    • The combined use of 99mTc-pertechnetate and 99mTc(Sn)-diphosphonate aids in differentiating cerebral infarctions from gliomas and metastases.
    • 99mTc(Sn)-diphosphonate is more effective for detecting cerebral infarctions.
    • 99mTc-pertechnetate is more effective for detecting brain tumors like gliomas and metastases.